Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Helius Medical Technologies Inc Reg S (HSM-S.TO)

Helius Medical Technologies Inc Reg S (HSM-S.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Helius Medical Technologies, Inc. to Present at the Benzinga Healthcare Small Cap Conference

NEWTOWN, Pa., Sept. 22, 2021 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq: HSDT) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, today announced...

HSM.TO : 18.35 (-1.71%)
HSM-S.TO : 1.98 (-1.49%)
HSDT : 5.07 (-1.36%)
Helius Medical Technologies, Inc. Appoints Paul Buckman to its Board of Directors

NEWTOWN, Pa., Sept. 14, 2021 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, today announced...

HSM.TO : 18.35 (-1.71%)
HSM-S.TO : 1.98 (-1.49%)
HSDT : 5.07 (-1.36%)
LIVN : 54.01 (+3.21%)
Helius Medical Technologies, Inc. to Present at the H.C. Wainwright 23rd Annual Global Investment Conference

NEWTOWN, Pa., Sept. 07, 2021 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (TSX:HSM) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, today...

HSM-S.TO : 1.98 (-1.49%)
HSDT : 5.07 (-1.36%)
HSM.TO : 18.35 (-1.71%)
Helius Medical Technologies, Inc. Announces Voluntary De-Listing from Toronto Stock Exchange

NEWTOWN, Pa., Aug. 25, 2021 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (TSX:HSM) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, today...

HSM-S.TO : 1.98 (-1.49%)
HSDT : 5.07 (-1.36%)
HSM.TO : 18.35 (-1.71%)
Helius Medical Technologies, Inc. Announces FDA Breakthrough Device Designation for the Treatment of Dynamic Gait and Balance Deficits Following a Stroke

NEWTOWN, Pa., Aug. 17, 2021 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (TSX:HSM) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, today...

HSM-S.TO : 1.98 (-1.49%)
HSDT : 5.07 (-1.36%)
HSM.TO : 18.35 (-1.71%)
Helius Medical Technologies, Inc. Reports Second Quarter 2021 Financial Results

NEWTOWN, Pa., Aug. 12, 2021 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (TSX:HSM) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, today...

HSM-S.TO : 1.98 (-1.49%)
HSDT : 5.07 (-1.36%)
HSM.TO : 18.35 (-1.71%)
Helius Medical Technologies, Inc. Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

NEWTOWN, Pa., Aug. 11, 2021 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq: HSDT ) (TSX: HSM ) (“Helius” or the “Company”), a neurotech company focused on neurological wellness,...

HSDT : 5.07 (-1.36%)
HSM.TO : 18.35 (-1.71%)
HSM-S.TO : 1.98 (-1.49%)
Helius Medical Technologies, Inc. Launches New Website for U.S.-Based Patients and Physicians

NEWTOWN, Pa., Aug. 11, 2021 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (TSX:HSM) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, today...

HSM-S.TO : 1.98 (-1.49%)
HSDT : 5.07 (-1.36%)
HSM.TO : 18.35 (-1.71%)
Helius Medical Technologies, Inc. to Present at Two Upcoming Investor Conferences in July

NEWTOWN, Pa., July 12, 2021 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (TSX:HSM) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, today...

HSM-S.TO : 1.98 (-1.49%)
HSDT : 5.07 (-1.36%)
HSM.TO : 18.35 (-1.71%)
Helius Medical Technologies, Inc. Appoints Antonella Favit-Van Pelt, M.D., Ph.D. as Chief Medical Officer

NEWTOWN, Pa., July 08, 2021 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (TSX:HSM) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, today...

HSM-S.TO : 1.98 (-1.49%)
HSDT : 5.07 (-1.36%)
HSM.TO : 18.35 (-1.71%)
JNJ : 149.12 (+0.82%)
TEVA : 12.88 (+0.16%)
BMY : 49.14 (+0.43%)

Barchart Exclusives

1 Cheap Dividend King With 14% Upside Potential
As the energy sector rides out the latest wave of volatility, one undervalued company with a fully integrated business model stands out from the crowd for income-seeking investors. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar